Three Strategic Bio Resources
Three strategic bio resources: 300,000+ strain bank, 178 fermented TCM base liquids, and million-scale knowledge graph — forming an irreplaceable moat.
About Us
Company Overview
Founded in 2015, Guangdong Longsee Biomedical is a national high-tech enterprise and national specialized "Little Giant". Built on three strategic biological resources and four proprietary technology platforms, the company forms a full-chain AI foundation for biomanufacturing.
Core Strengths
What Drives Us
Four Proprietary Technology Platforms
Four proprietary platforms covering discovery, screening, precision production and AI application — full-chain intelligence from collection to use.
Four Core Business Segments
Four segments: novel raw materials, product matrix, clinical service packages, and CRDMO services.
R&D & Partnerships
Research Strength & Partnership Network
282 patent applications (135 granted), 200+ publications in Nature, Science, Cell; partnerships with 30+ institutes and 300+ medical institutions across 20+ countries.
282+Patent Applications
135Patents Granted
300+Publications
30+Research Institutes
300+Medical Institutions
30+Countries & Regions